AG-120

ivosidenib · Agios Pharmaceuticals

Drug timelines are a Plus or Pro feature.

6 regulatory and trial events tracked for AG-120, covering 2015-12-14 to 2026-04-23. Get the full timeline:

Most recent: Clinical Trial Update: AG-120 in People With IDH1 Mutant Chondrosarcoma [Phase 2]